Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Passionfruit leaf (Passiflora edulis) is rich in bioactive C-glycosyl flavonoids—including vitexin, isovitexin, orientin, and chrysin—as well as harmane-type alkaloids and saponins that positively modulate GABA-A receptor activity to promote anxiolysis, sedation, and improved sleep quality (He X et al., Front Pharmacol, 2020; PMID 32508631). Sub-acute toxicity evaluation in Wistar rats has confirmed the safety profile of aqueous P. edulis leaf extracts at tested doses, while mycorrhizal inoculation studies demonstrate that cultivation conditions can significantly enhance the yield of these anxiolytic biomolecules in yellow passionfruit leaves (Rodríguez-Usaquén A et al., Toxicol Rep, 2023; PMID 37955035; de Oliveira PTF et al., J Sci Food Agric, 2019; PMID 30666655).
Reported Benefits (Provisional)
Origin & History
Passionfruit Leaf is derived from *Passiflora edulis*, a tropical vine native to South America, particularly Brazil, Paraguay, and Argentina. It thrives in warm, tropical climates and is valued for its rich array of bioactive compounds that support systemic wellness.
Research Narrative (Provisional)
A comprehensive phytochemical and pharmacological review by He et al. (2020) in Frontiers in Pharmacology (PMID 32508631) documented that Passiflora edulis leaves contain flavonoids (vitexin, isovitexin, orientin, chrysin), alkaloids, phenolic acids, and saponins with demonstrated anxiolytic, sedative, anti-inflammatory, and antioxidant activities in preclinical models. De Oliveira et al. (2019) in the Journal of the Science of Food and Agriculture (PMID 30666655) showed that mycorrhizal inoculation of yellow passionfruit (P. edulis f. flavicarpa) significantly increased leaf concentrations of orientin, vitexin, and isovitexin—key biomolecules of interest to the anxiolytic herbal medicine industry. Rodríguez-Usaquén et al. (2023) in Toxicology Reports (PMID 37955035) conducted a sub-acute toxicity evaluation of aqueous leaf extract from P. edulis Sims f. edulis (gulupa) in Wistar rats, finding no significant adverse effects on hematological, biochemical, or histopathological parameters at tested doses, supporting its safety for potential therapeutic use. Kim et al. (2017) in the Journal of Menopausal Medicine (PMID 29354614) reviewed the closely related Passiflora incarnata, confirming the genus-wide relevance of flavonoid-mediated GABA-A modulation for anxiolytic and sedative outcomes.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Flavonoids: Including vitexin, isovitexin, orientin, and chrysin, providing antioxidant and anti-inflammatory protection. - Alkaloids: Such as harman, contributing to sedative and anxiolytic properties. - Polyphenols: A broad class of compounds supporting immune modulation and inflammation regulation. - Dietary Fiber: Supporting digestive health and microbiome balance. - Minerals: Including magnesium, potassium, and calcium, essential for cardiovascular health and muscle function.
Reported Mechanism (Provisional)
The anxiolytic and sedative properties of passionfruit leaf are primarily driven by C-glycosyl flavonoids—vitexin, isovitexin, orientin, and chrysin—which function as positive allosteric modulators at the benzodiazepine binding site of the GABA-A receptor, enhancing chloride ion (Cl⁻) influx into neurons and producing dose-dependent neuronal inhibition analogous to benzodiazepines (He et al., 2020; PMID 32508631). Harmane-type β-carboline alkaloids present in the leaf complement this mechanism by inhibiting monoamine oxidase (MAO), thereby elevating synaptic levels of serotonin and norepinephrine, contributing to anxiolytic and mood-stabilizing effects. Additionally, phenolic acids and proanthocyanidins exert potent free-radical scavenging activity via electron donation and metal chelation, reducing oxidative stress markers such as DPPH and ABTS radicals, while triterpenoid saponins contribute antispasmodic effects through calcium channel modulation in smooth muscle tissue. These multi-target mechanisms—GABAergic potentiation, monoamine preservation, antioxidant defense, and smooth muscle relaxation—collectively explain the broad therapeutic profile attributed to P. edulis leaf preparations.
Clinical Narrative (Provisional)
Scientific research validates passionfruit leaf's anxiolytic and sedative properties through primarily in vitro and animal studies, with limited human clinical trial data available. Studies demonstrate cardiovascular benefits including blood pressure reduction, though specific quantified outcomes and sample sizes are not well-documented in current literature. The antioxidant and anti-inflammatory effects have been confirmed through laboratory assays, but comprehensive human randomized controlled trials with measurable efficacy percentages are lacking. Current evidence strength is moderate, based predominantly on preclinical research rather than robust clinical trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.